Genetics of primary intracerebral hemorrhage.

Genetic studies of primary intracerebral hemorrhage (PICH) have begun to yield important biologic insights into the pathogenesis of this disorder. This review of candidate genes for PICH emphasizes the value of focusing on individual pathogenic phenotypes. One type of PICH in particular, cerebral amyloid angiopathy, is known to have specific genetic factors regulating both its familial and sporadic forms. Another promising research method is to focus on pathways involved in hemostasis that may be etiologically relevant to all types of PICH. Genetic studies will improve our understanding of the biology of PICH, and may eventually be incorporated into clinical decision making regarding anticoagulation.

[1]  J. Szaflarski,et al.  Genetic and Environmental Risk Factors for Intracerebral Hemorrhage: Preliminary Results of a Population-Based Study , 2002, Stroke.

[2]  C. Graffagnino,et al.  Familial Clustering of Intracerebral Hemorrhage: A Prospective Study in North Carolina , 2001, Neuroepidemiology.

[3]  S. Greenberg,et al.  Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein* , 2001, The Journal of Biological Chemistry.

[4]  S. Tognazzo,et al.  A common mutation in the gene for coagulation factor XIII‐A (VAL34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases , 2001, American journal of hematology.

[5]  D. Mann,et al.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. , 2001, The American journal of pathology.

[6]  M. Alberts.  Genetics update : impact of the human genome projects and identification of a stroke gene. , 2001, Stroke.

[7]  T. Grabowski,et al.  Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy , 2001, Annals of neurology.

[8]  J. Corral,et al.  Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage. , 2001, Blood.

[9]  J. Marler,et al.  Advances in the genetics of cerebrovascular disease and stroke , 2001, Neurology.

[10]  S. Greenberg,et al.  Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.

[11]  S. Greenberg,et al.  Warfarin-associated hemorrhage and cerebral amyloid angiopathy , 2000, Neurology.

[12]  M. Maurer,et al.  Examining Thrombin Hydrolysis of the Factor XIII Activation Peptide Segment Leads to a Proposal for Explaining the Cardioprotective Effects Observed with the Factor XIII V34L Mutation* , 2000, The Journal of Biological Chemistry.

[13]  P. Eisenhauer,et al.  Toxicity of various amyloid β peptide species in cultured human blood–brain barrier endothelial cells: Increased toxicity of Dutch‐type mutant , 2000, Journal of neuroscience research.

[14]  B Frangione,et al.  Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. , 2000, The Journal of biological chemistry.

[15]  S. Mead,et al.  Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings. , 2000, Brain : a journal of neurology.

[16]  W. V. Van Nostrand,et al.  Charge Alterations of E22 Enhance the Pathogenic Properties of the Amyloid β‐Protein , 2000 .

[17]  P. Grant,et al.  Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. , 2000, Blood.

[18]  H. Vinters,et al.  Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. , 2000, Stroke.

[19]  A. Tamaoka,et al.  Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy , 2000, Journal of neurology, neurosurgery, and psychiatry.

[20]  K. Furie,et al.  Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. , 2000, The New England journal of medicine.

[21]  R. Sacco,et al.  Lobar intracerebral hemorrhage. , 2000, The New England journal of medicine.

[22]  F. Cambien,et al.  The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. , 2000, Blood.

[23]  S. Love,et al.  Absence of cystatin C mutation in sporadic cerebral amyloid angiopathy–related hemorrhage , 2000, Neurology.

[24]  D. Graham,et al.  The Apolipoprotein E ∈2 Allele and the Pathological Features in Cerebral Amyloid Angiopathy-related Hemorrhage , 1999 .

[25]  D. Selkoe,et al.  Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.

[26]  Agueda Rostagno,et al.  A stop-codon mutation in the BRI gene associated with familial British dementia , 1999, Nature.

[27]  B. Brooke,et al.  Defective angiogenesis in mice lacking endoglin. , 1999, Science.

[28]  P. Reitsma,et al.  Factor XIII Val34Leu Is a Genetic Factor Involved in the Aetiology of Venous Thrombosis , 1999, Thrombosis and Haemostasis.

[29]  S. Nakashima,et al.  Polymorphism of the endoglin gene in patients with intracranial saccular aneurysms. , 1999, Journal of neurosurgery.

[30]  G. Aithal,et al.  Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications , 1999, The Lancet.

[31]  P. Grant,et al.  Association of a Common Polymorphism in the Factor XIII Gene With Venous Thrombosis , 1999 .

[32]  A. Markham,et al.  Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. , 1999, Blood.

[33]  P. Board,et al.  The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. , 1998, Blood.

[34]  P. Grant,et al.  A Common Coding Polymorphism in the FXIII A-subunit Gene (FXIIIVAL34LEU) Affects Cross-linking Activity , 1998, Thrombosis and Haemostasis.

[35]  C. Broeckhoven,et al.  Flemish and Dutch Mutations in Amyloid β Precursor Protein Have Different Effects on Amyloid β Secretion , 1998, Neurobiology of Disease.

[36]  A. Hofman,et al.  Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala→Gly mutation , 1998, Acta Neuropathologica.

[37]  T. Imaizumi,et al.  A Mutation in Plasma Platelet-activating Factor Acetylhydrolase (Val279Phe) Is a Genetic Risk Factor for Cerebral Hemorrhage but not for Hypertension , 1998, Thrombosis and Haemostasis.

[38]  J. Nicoll,et al.  High frequency of apolipoprotein E ϵ2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage , 1998, Neuroscience Letters.

[39]  S. Greenberg,et al.  Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy , 1998, Neurology.

[40]  B T Hyman,et al.  Progression of Cerebral Amyloid Angiopathy: Accumulation of Amyloid-ß40 in Affected Vessels , 1998, Journal of neuropathology and experimental neurology.

[41]  S. M. Sumi,et al.  Amyloid angiopathy in a volga german family with Alzheimer's disease and a presenilin‐2 mutation (N141I) , 1998, Annals of neurology.

[42]  C. Broeckhoven,et al.  Mortality from hereditary cerebral haemorrhage with amyloidosis--Dutch type. The impact of sex, parental transmission and year of birth. , 1997, Brain : a journal of neurology.

[43]  T. Imaizumi,et al.  A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke. , 1997, Stroke.

[44]  E. Otomo,et al.  Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. , 1997, Stroke.

[45]  H. Vinters,et al.  Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies. , 1997, Human pathology.

[46]  W. Trager,et al.  Genetic association between sensitivity to warfarin and expression of CYP2C9*3. , 1997, Pharmacogenetics.

[47]  D. Graham,et al.  High frequency of apolipoprotein E ϵ2 Allele in hemorrhage due to cerebral amyloid angiopathy , 1997, Annals of neurology.

[48]  C. Graffagnino,et al.  Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhage , 1997, Annals of neurology.

[49]  M. Yamada,et al.  Cerebral amyloid angiopathy in the elderly: the clinicopathological features, pathogenesis, and risk factors. , 1997, Journal of medical and dental sciences.

[50]  M. Verbeek,et al.  Rapid Degeneration of Cultured Human Brain Pericytes by Amyloid β Protein , 1997 .

[51]  Bradley T. Hyman,et al.  Apolipoprotein E ε4 Is Associated With the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid Angiopathy , 1996 .

[52]  L. Thal,et al.  The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant , 1996, Neurology.

[53]  R N Kalaria,et al.  Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. , 1996, The American journal of pathology.

[54]  W. V. Van Nostrand,et al.  Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[55]  C. Graffagnino,et al.  Cystatin C mutation in an elderly man with sporadic amyloid angiopathy and intracerebral hemorrhage. , 1995, Stroke.

[56]  B. Hyman,et al.  Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy , 1995 .

[57]  G. Bots,et al.  Hereditary cerebral haemorrhage with amyloidosis, Dutch type (HCHWA-D): clinicopathological studies. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[58]  C. Soto,et al.  The -Helical to -Strand Transition in the Amino-terminal Fragment of the Amyloid -Peptide Modulates Amyloid Formation * , 1995, The Journal of Biological Chemistry.

[59]  E. Hylek,et al.  Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.

[60]  M. Losowsky,et al.  Factor XIII: inherited and acquired deficiency. , 1993, Blood reviews.

[61]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Donald Martin,et al.  Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study , 1993, Annals of Internal Medicine.

[63]  D. Selkoe,et al.  Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein. , 1992, Biochemistry.

[64]  J. Hardy,et al.  Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). , 1990, Science.

[65]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[66]  H. Vinters,et al.  Stroke related to cerebral amyloid angiopathy: the significance of systemic vascular disease , 1989, Journal of Neurology.

[67]  C. López-Otín,et al.  Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases , 1989, The Journal of experimental medicine.

[68]  I. Olafsson,et al.  MUTATION IN CYSTATIN C GENE CAUSES HEREDITARY BRAIN HAEMORRHAGE , 1988, The Lancet.

[69]  M. Sheridan.  Letter: The handicapped family. , 1975 .

[70]  Fisher Cm.  Pathological observations in hypertensive cerebral hemorrhage. , 1971 .

[71]  M. Zago,et al.  Factor XIII val34leu and the risk of myocardial infarction. , 2000, Haematologica.

[72]  A. Carter,et al.  Association of a Common Polymorphism in the Factor XIII Gene with Myocardial Infarction , 1998, Thrombosis and Haemostasis.

[73]  S. Kobayashi,et al.  No mutations in cystatin C gene in cerebral amyloid angiopathy with cystatin C deposition. , 1998, Molecular and chemical neuropathology.

[74]  P. Patton.  Risk factors for complications of chronic anticoagulation , 1994 .

[75]  D. W. Johnson,et al.  Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.

[76]  A. Hofman,et al.  Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene , 1992, Nature Genetics.